Glutamate uptake is reduced in prefrontal cortex in Huntington's disease

Neurochemical Research

Volumn 33, Issue 2, 2008, Pages 232-237

  Hassel, Bjørnar ^a,b,c   Tessler, Shoshi ^b   Faull, Richard L M ^d   Emson, Piers C ^b  

^a NORWEGIAN DEFENCE RESEARCH ESTABLISHMENT FFI   (Norway)

^b BABRAHAM INSTITUTE   (United Kingdom)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Astrocyte; CAG repeat expansion; EAAT2; Glutamate uptake; Huntington; Proteoliposome

Indexed keywords

AMPA RECEPTOR; CYSTEINYLALANYLGLYCINE; DITHIOTHREITOL; EXCITATORY AMINO ACID TRANSPORTER; GLUTAMIC ACID; HUNTINGTIN; REDUCING AGENT; REPETITIVE DNA; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO ACID TRANSPORT; ARTICLE; ASTROCYTE; AUTOPSY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; MALE; NERVE DEGENERATION; PREFRONTAL CORTEX; PRIORITY JOURNAL; SYNAPSE;

ASTROCYTES; BIOLOGICAL TRANSPORT; GLUTAMIC ACID; HUMANS; HUNTINGTON DISEASE; PREFRONTAL CORTEX; TRINUCLEOTIDE REPEATS;

ANIMALIA;

EID: 38349101590     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-007-9463-1     Document Type: Article

References (36)

1. The Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72:971-983
2. Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, Bates GP (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493-506
3. Hebb MO, Denovan-Wright EM, Robertson HA (1999) Expression of the Huntington's disease gene is regulated in astrocytes in the arcuate nucleus of the hypothalamus of postpartum rats. FASEB J 13:1099-1106
4. Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr (1985) Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 44:559-577
5. Young AB, Greenamyre JT, Hollingsworth Z, Albin R, D'Amato C, Shoulson I, Penney JB (1988) NMDA receptor losses in putamen from patients with Huntington's disease. Science 241:981-983
6. Albin RL, Young AB, Penney JB, Handelin B, Balfour R, Anderson KD, Markel DS, Tourtellotte WW, Reiner A (1990) Abnormalities of striatal projection neurons and N-methyl-d-aspartate receptors in presymptomatic Huntington's disease. N Engl J Med 322:1293-1298
7. Schwarcz R, Whetsell WO Jr, Mangano RM (1983) Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science 219:316-318
8. Beal MF, Kowall NW, Ellison DW, Mazurek MF, Swartz KJ, Martin JB (1986) Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature 321:168-171
9. Danbolt NC (2001) Glutamate uptake. Prog Neurobiol 65:1-105
10. Arzberger T, Krampfl K, Leimgruber S, Weindl A (1997) Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington's disease-an in situ hybridization study. J Neuropathol Exp Neurol 56:440-454
11. Liévens JC, Woodman B, Mahal A, Spasic-Boscovic O, Samuel D, Kerkerian-Le Goff L, Bates GP (2001) Impaired glutamate uptake in the R6 Huntington's disease transgenic mice. Neurobiol Dis 8:807-821
12. Behrens PF, Franz P, Woodman B, Lindenberg KS, Landwehrmeyer GB (2002) Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation. Brain 125:1908-1922
13. Shin JY, Fang ZH, Yu ZX, Wang CE, Li SH, Li XJ (2005) Expression of mutant Huntington in glial cells contributes to neuronal excitotoxicity. J Cell Biol 171:1001-1012
14. +]coupled l-glutamate transporter purified from rat brain is located in glial cell processes. Neuroscience 51:295-310
15. Haugeto Ø, Ullensvang K, Levy LM, Chaudhry FA, Honoré T, Nielsen M, Lehre KP, Danbolt NC (1996) Brain glutamate transporter proteins form homomultimers. J Biol Chem 271:27715-27722
16. Hassel B, Boldingh KA, Narvesen C, Iversen EG, Skrede KK (2003) Glutamate transport, glutamine synthetase and phosphate-activated glutaminase in rat CNS white matter. A quantitative study. J Neurochem 87:230-237
17. Warner JP, Barron LH, Brock DJ (1993) A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes. Mol Cell Probes 7:235-239
18. Danbolt NC, Pines G, Kanner BI (1990) Purification and reconstitution of the sodium- and potassium-coupled glutamate transport glycoprotein from rat brain. Biochemistry 29:6734-6740
19. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685
20. Lehre KP, Levy LM, Ottersen OP, Storm-Mathisen J, Danbolt NC (1995) Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations. J Neurosci 15:1835-1853
21. Hassel B, Bachelard H, Jones P, Fonnum F, Sonnewald U (1997) Trafficking of amino acids between neurons and glia in vivo. Effects of inhibition of glial metabolism by fluoroacetate. J Cereb Blood Flow Metab 17:1230-1238
22. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
23. Penney JB Jr, Vonsattel JP, MacDonald ME, Gusella JF, Myers RH (1997) CAG repeat number governs the development rate of pathology in Huntington's disease. Ann Neurol 41:689-692
24. Culjkovic B, Stojkovic O, Vojvodic N, Svetel M, Rakic L, Romac S, Kostic V (1999) Correlation between triplet repeat expansion and computed tomography measures of caudate nuclei atrophy in Huntington's disease. J Neurol 246:1090-1093
25. Trotti D, Rossi D, Gjesdal O, Levy LM, Racagni G, Danbolt NC, Volterra A (1996) Peroxynitrite inhibits glutamate transporter subtypes. J Biol Chem 271:5976-5979
26. Whitehouse PJ, Trifiletti RR, Jones BE, Folstein S, Price DL, Snyder SH, Kuhar MJ (1985) Neurotransmitter receptor alterations in Huntington's disease: autoradiographic and homogenate studies with special reference to benzodiazepine receptor complexes. Ann Neurol 18:202-210
27. Fonnum F (1984) Glutamate: a neurotransmitter in mammalian brain. J Neurochem 42:1-11
28. Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW, Kanai Y, Hediger MA, Wang YF, Schielke JP, Welty DF (1996) Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16:675-686
29. Tanaka K, Watase K, Manabe T, Yamada K, Watanabe M, Takahashi K, Iwama H, Nishikawa T, Ichihara N, Kikuchi T, Okuyama S, Kawashima N, Hori S, Takimoto M, Wada K (1997) Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 276:1699-1702
30. Perry TL, Hansen S, Kloster M (1973) Huntington's chorea. Deficiency of gamma-aminobutyric acid in brain. N Engl J Med 288:337-342
31. Enna SJ, Bird ED, Bennett JP Jr, Bylund DB, Yamamura HI, Iversen LL, Snyder SH (1976) Huntington's chorea. Changes in neurotransmitter receptors in the brain. N Engl J Med 294:1305-1309
32. Ellison DW, Beal MF, Mazurek MF, Malloy JR, Bird ED, Martin JB (1987) Amino acid neurotransmitter abnormalities in Huntington's disease and the quinolinic acid animal model of Huntington's disease. Brain 110:1657-1673
33. Strong TV, Tagle DA, Valdes JM, Elmer LW, Boehm K, Swaroop M, Kaatz KW, Collins FS, Albin RL (1993) Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues. Nat Genet 5:259-265
34. Tobin AJ, Signer ER (2000) Huntington's disease: the challenge for cell biologists. Trends Cell Biol 10:531-536
35. Liévens JC, Rival T, Iche M, Chneiweiss H, Birman S (2005) Expanded polyglutamine peptides disrupt EGF receptor signaling and glutamate transporter expression in Drosophila. Hum Mol Genet 14:713-724
36. Diaz-Hernandez M, Torres-Peraza J, Salvatori-Abarca A, Moran MA, Gomez-Ramos P, Alberch J, Lucas JJ (2005) Full motor recovery despite striatal neuron loss and formation of irreversible amyloid-like inclusions in a conditional mouse model of Huntington's disease. J Neurosci 25:9773-9781